| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |